Superiority of endothelin-1 over norepinephrine in exercise-induced alterations of the conduit artery tone of the non-exercised arm in patients with chronic heart failure

International Journal of Cardiology

Volumn 73, Issue 1, 2000, Pages 15-25

  Yousufuddin, Mohammed ^a   Shamim, Waqar ^a   Chambers, Jonathan S ^a   Henein, Michael ^a   Amin, Fouad R ^a   Anker, Stefan D ^a   Kemp, Michael ^a   Hooper, James ^a   Coats, Andrew J S ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Chronic heart failure; Endothelin 1; Exercise; Norepinephrine; Vascular tone

Indexed keywords

ENDOTHELIN 1; NORADRENALIN;

ADULT; ARTERY BLOOD FLOW; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTERY TONE; ARTICLE; BLOOD FLOW; BLOOD VESSEL TONE; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; HEART FAILURE; HUMAN; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL;

BRACHIAL ARTERY; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; EXERCISE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NOREPINEPHRINE; REGIONAL BLOOD FLOW; VASOCONSTRICTION; VASOMOTOR SYSTEM;

EID: 0034737560     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(99)00200-4     Document Type: Article

References (27)

1. Hales S. Statistical essays. History of medicine series, library, New York Academy of Medicine. 1964;Harvard Publishing, New York.
2. Ramsey M.W., Goodfellow J., Jones C.J., Luddington L.A., Lewis M.J., Henderson A.H. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation. 92:1995;3212-3219.
3. Maruyama Y., Nishioka O., Nozaki E., Kinoshita H., Kyono H.K.Y., Takishima T. Effects of arterial distensibility on left ventricular ejection fraction in the depressed contractile state. Cardiovasc Res. 27:1993;182-187.
4. Treasure C.B., Vita J.A., Cox D.A. Endothelium dependent dilatation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 81:1990;779.
5. Drexler H., Hayoz D., Munzel T., et al. Endothelial function in chronic congestive heart failure. Am J Cardiol. 69:1992;1596-1601.
6. Katz S.D. The role of endothelium-derived vasoactive substances in the pathophysiology of exercise intolerance in patients with congestive heart failure. Prog Cardiovasc Dis. 38:1995;23-50.
7. Luscher T.F., Vanhoutte P.M. The endothelium: modulator of cardiovascular function. 1990;1-228 CRC Press, Boca Raton, FL.
8. Zelis R., Longhurst J., Capone R.J., Mason D.N. A comparison of regional blood flow and oxygen utilization during dynamic forearm exercise in normal subjects and patients with congestive heart failure. Circulation. 50:1974;137-143.
9. Dzau V.J.C.W.H.N., Williams G.H. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation. 63:1981;651.
10. Cohn J.N. Plasma norepinephrine and mortality. Clin Cardiol. 18:1995;I9-12.
11. Cohn J.N., Levine T.B., Oliveri M.T., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. New Engl J Med. 311:1984;819-823.
12. Creager M.A., Faxon D.P., Cutler S.S., Kohlman O., Ryan T.J., Gavaras H. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with renin-angiotensin system and sympathetic nervous system. J Am Coll Cardiol. 7:1986;758-765.
13. Henderson A.H. Endothelium in control (St. Cyres lecture). Br Heart J. 65:1991;116-125.
14. Vane J.R., Anggard E.E., Botting R.M. Regulatory functions of the vascular endothelium. New Engl J Med. 323:1990;27-36.
15. Gilligan D.M., Panza J.A., Kilcoyne C.M., Waclawiw M.A., Casin P.R., Quyyumi A.A. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation. 90:1994;2853-2858.
16. Haynes W.G., Webb D. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet. 344:1994;852-854.
17. Katz S.D., Krum H., Khan T., Knecht M. Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide. J Am Coll Cardiol. 28:1996;585-590.
18. Zelis R., Mason D.T., Braunwald E. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest. 47:1968;960-970.
19. Celermajer D.S., Sorensen K.E., Gooch V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115.
20. Henderson A.H. Endothelial dysfunction: a reversible clinical measure of atherogenic susceptibility and cardiovascular inefficiency. Int J Cardiol. 62:1997;S43-S48.
21. Celermajer D.S. Testing endothelial function using ultrasound. J Cardiovasc Pharmacol. 32:1998;S29-S32.
22. Khder Y., Ghawi R.El, Bosc L.B., Aliot E., Zannad F. Investigation of the peripheral vascular mechanisms implicated in congestive heart failure by non-invasive evaluation of radial artery compliance and reactivity. Int J Cardiol. 56:1996;149-158.
23. Yanagisawa M., Kurihara H., Kimura S., et al. A novel potent vasoconstrictor peptide produced vascular endothelial cells. Nature. 332:1988;411-415.
24. Rodeheffer R.J., Lerman A., Heublein D.M., Burnett J.C.J. Increased plasma concentration of endothelin in chronic heart failure in humans. Mayo Clin Proc. 67:1992;719-724.
25. Cody R.J. The potential role of endothelin as a vasoconstrictor substance in congestive heart failure. Eur Heart J. 13:1992;1573-1578.
26. Cannan C.R., Burnett J.C.J., Lerman A. Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure. Circulation. 93:1996;646-651.
27. Kiowski W., Sutsch G., Hunziker P., et al. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet. 346:1995;732-736.